Conference Coverages (Video Content)


ASCO 2010: The Human Genome Project and Cancer Advances

Bruce Johnson, MD, discusses the human genome project and how it has helped advancements in cancer treatment. Selma R. Schimmel, Founder & CEO, Vital Options International: Dr. Johnson, with all of... Continue Reading

ASCO 2010: What is the “FISH” Test?

Bruce E. Johnson, MD, Professor of Medicine at Harvard Medical School sat with Understanding Cancer at ASCO this year to discuss exciting new data in lung cancer.  Here he talks about a specific assay... Continue Reading

ASCO 2010: ALK Gene, Exciting News for Some Lung Cancer Patients

Bruce Johnson, MD discusses the exciting new ALK gene clinical trial data benfitting a subset of lung cancer patients. Selma R. Schimmel, Founder & CEO, Vital Options International: Hello, Dr. Bruce... Continue Reading

ASCO 2010: Lymphoma Maintenance Therapy, An Advocate Perspective

Brian Tomlinson, from the Lymphoma Research Foundation, discusses lymphoma maintenance therapy. Selma R. Schimmel, Founder & CEO, Vital Options International: Brian Tomlinson, you are the Director... Continue Reading

ASCO 2010: What’s Next for CML Patients?

Dr. Sonali Smith discusses treatment innovations for CML. Selma R. Schimmel, Founder & CEO, Vital Options International: What happens now in the research? What is the next phase? Sonali Smith, MD,... Continue Reading

ASCO 2010: Treating CML

Dr. Sonali Smith discusses the newest developments in the treatment of CML. Selma R. Schimmel, Founder & CEO, Vital Options International: I’m very excited to be able to talk about some of the fantastic... Continue Reading

ASCO 2010: New Treatments for CML

Dr. Jorge Cortes discusses new data on bosutinib, a new tyrosine kinase inhibitor for CML. Selma R. Schimmel, Founder & CEO, Vital Options International: Dr. Jorge Cortes. You are the deputy chair... Continue Reading

ASCO 2010: Vitamin D and Lifestyle Choices

Dr. Joanne Mortimer, Vice Chair of Medical Oncology at City of Hope, discusses the importance of vitamin D. Joanne Mortimer, M.D., Vice Chair, Medical Oncology, City of Hope: So obviously one of the hardest... Continue Reading

ASCO 2010: How Do New Drugs Get Developed?

Dr. Michael Boyer, Head of Medical Oncology at Sydney Cancer Center, explains the process for new drug development. Selma R. Schimmel, Founder & CEO, Vital Options International: What is the drug development... Continue Reading

ASCO 2010: Clinical Trials and Advanced Non-small Cell Lung Cancer

Dr. Michael Boyer, Head of Medical Oncology at Sydney Cancer Center, discusses data for PF299804. Selma R. Schimmel, Founder & CEO, Vital Options International: Hello Dr. Boyer. Michael J. Boyer,... Continue Reading

ASCO 2010: Chemotherapy and Heart Disease

Joanne Mortimer from City of Hope discusses the heart risks associated with chemotherapy. Selma R. Schimmel, Founder & CEO, Vital Options International: Dr. Mortimer, there’s been talk at this meeting... Continue Reading

ASCO 2010: Older Women with Breast Cancer May Skip Radiation Therapy

Joanne Mortimer from the City of Hope Cancer Center discusses research indicating that older women may not need aggressive treatment. Selma R. Schimmel, Founder & CEO, Vital Options International:... Continue Reading

ASCO 2010: Setting the Record Straight on the Breast Cancer Vaccine

At ASCO 2010, Derek Raghavan clarifies the misinformation surrounding a potential new breast cancer vaccine. There is hope…but it’s still five to ten years away from use in humans. Selma R.... Continue Reading

ASCO 2010: How Will Healthcare Reform Affect Cancer Care?

Derek Raghavan, Director of the Taussig Cancer Institute, discusses the impact of healthcare reform on cancer care. Selma R. Schimmel, Founder & CEO, Vital Options International: In this new world... Continue Reading

ASCO 2010: Lung Cancer in Young Women Who Have Never Smoked

Joan Schiller, Deputy Director of Simmons Cancer Center, discusses new research that shows an increased prevalence of lung cancer in young women never-smokers. Joan Schiller, M.D., Deputy Director, Simmons... Continue Reading

SABCS 2009: Bisphosphonates and Breast Cancer

Dr. Gad Rennert from Israel and Dr. Rowan Chlebowski from UCLA discuss their research with bisphosphonates and breast cancer. NARRATOR: Studies presented at the 2009 San Antonio Breast Cancer Symposium... Continue Reading

SABCS 2009: History of the San Antonio Breast Cancer Symposium

The history of the San Antonio Breast Cancer Symposium and how it became one of the most important components of breast cancer research. C. Kent Osborne, M.D., Co-Founder, San Antonio Breast Cancer... Continue Reading

SABCS 2009: Mammography Screening Controversy

Doctors and advocates at the 2009 San Antonio Breast Cancer Symposium chime in regarding the new mammography screening guidelines. NARRATOR: For the first time in eight years, the government has released... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS